Home > Formulary : Adult > Chapters > 2. Cardiovascular System >
BNSSG Adult Joint Formulary
2.8 Oedema
Last edited: 20-05-2024
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Diuretics
Loop Diuretics
Recommended: (TLS Green)
Furosemide
Alternative: (TLS Blue)
Bumetanide
- Bumetanide is significantly more expensive than Furosemide in primary care
- If an IV loop diuretic is required, Furosemide is recommended
Co-amilofruse
Osmotic Diuretics
Recommended: (TLS Red)
Mannitol Infusion 20%
Potassium-sparing diuretics
Recommended: (TLS Green)
Amiloride
Thiazides and Related Diuretics
Thiazide-like diuretics are third-line agents when used in the treatment of hypertension. See NICE clinical guidance CG127
Recommended: (TLS Green)
Indapamide 2.5mg tablets
Alternative: (TLS Blue)
Bendroflumethiazide 2.5mg tablets
Specific Indications: (TLS Blue)
Indapamide 1.5mg modified-release tablets
- When initiated by stroke physicians
Chlorthalidone
- Benign intracranial hypertension
Metolazone
- For use in combination with a loop diuretic
- Healthcare professionals should exercise caution when switching patients between metolazone preparations. See guidance from MHRA and SPS for further information.
Carbonic Anhydrase Inhibitors
Specific indication: (TLS Blue)
Acetazolamide 250mg tablets
- Benign intracranial hypertension (unlicensed)
For use of acetazolamide:
Diuretics with potassium
None
- Most patients on diuretics do not require potassium supplements. The amount of potassium in combined preparations is insufficient for those patients requiring supplementation, therefore their use is discouraged. Potassium sparing diuretics are more effective than using potassium supplements in maintaining potassium levels.
Contact Us
Got a question or comment about the Joint Formulary?
Please use the email address below to contact us and we will endeavour to respond within 2 working days.